糖尿病护理设备和药物市场规模、份额及成长分析（按类型、分销管道、最终用途和地区）－2025-2032 年产业预测

2023 年糖尿病护理设备和药物市场规模价值 301.8 亿美元，预计将从 2024 年的 325.6 亿美元增长到 2032 年的 598.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.9%。

透过调节胰岛素来控制血糖值对于糖尿病患者来说至关重要。根据国际糖尿病联盟的数据，糖尿病是一个迅速增长的全球健康问题，影响着约 5.37 亿成年人。糖尿病，尤其是第 2 型糖尿病的盛行率不断上升，主要是由于肥胖率上升、不健康饮食和久坐的生活方式，尤其是在中低收入国家。患者数量的增加极大地推动了对糖尿病护理设备的需求，包括简化血糖值管理的连续血糖监测仪。由于医疗成本上升，尤其是第 2 型糖尿病诊断数量的增加，预计市场将会成长。市场区隔正在增加对技术创新的投资，以增强胰岛素输送装置，旨在在这个重要的医疗保健领域占据更大的市场占有率。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

糖尿病护理设备和药物市场规模（按类型和复合年增长率）（2025-2032）

• 市场概览
• BGM设备
  • 自我监测设备
  • 血糖值仪
  • 测试条
  • 《采血针》
  • 连续血糖监测装置
  • 感应器
  • 发送器
  • 接收器
• 胰岛素给药装置
  • 泵浦
  • 笔
  • 注射器和针头
  • 喷射注射器

糖尿病护理设备和药物市场规模（按分销管道和复合年增长率）（2025-2032）

• 市场概览
• 医院药房
• 零售药局
• 糖尿病诊所/中心
• 网路药局
• 其他的

糖尿病护理设备和药物市场规模（按最终用途和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 诊断中心
• 居家照护

糖尿病照护设备及药物市场规模（按地区及复合年增长率）（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Novo Nordisk（Denmark）
• Medtronic（Ireland）
• Abbott Laboratories（United States）
• Johnson & Johnson（United States）
• Biocon（India）
• Eli Lilly and Company（United States）
• Roche（Switzerland）
• Bayer（Germany）
• Dexcom（United States）
• Insulet Corporation（United States）
• Tandem Diabetes Care（United States）
• Ascensia Diabetes Care（Switzerland）
• Terumo Corporation（Japan）
• Becton, Dickinson and Company（United States）
• AstraZeneca（United Kingdom）
• Pfizer（United States）
• Merck & Co.（United States）
• GlaxoSmithKline（United Kingdom）
• McKesson Corporation（United States）

结论和建议

Diabetes Care Devices and Drugs Market size was valued at USD 30.18 billion in 2023 and is poised to grow from USD 32.56 billion in 2024 to USD 59.83 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The management of blood glucose levels through insulin regulation is critical for individuals with diabetes, a rapidly rising global health concern affecting approximately 537 million adults according to the International Diabetes Federation. The increasing prevalence of diabetes, particularly type 2, largely stems from rising obesity rates, unhealthy diets, and sedentary lifestyles, especially in low- and middle-income countries. This growing patient population significantly drives the demand for diabetes care devices, including continuous glucose monitors, which simplify glucose management. The market is poised for growth as healthcare costs escalate alongside the rising number of diagnoses, particularly for type 2 diabetes. Manufacturers are increasingly investing in technological innovations to enhance insulin delivery devices, aiming to capture larger market shares in this vital healthcare segment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Diabetes Care Devices And Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Diabetes Care Devices And Drugs Market Segments Analysis

Global Diabetes Care Devices and Drugs Market is segmented by Type, Distribution Channel, End-use and region. Based on Type, the market is segmented into BGM Devices and Insulin Delivery Devices. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Diabetes Care Devices And Drugs Market

One of the primary catalysts for the expansion of the global diabetes care devices and drugs market is the continuous introduction of innovative products aimed at diabetes monitoring and treatment. A notable example is the research conducted by the Universidade de Lisboa in Portugal, which demonstrated in April 2020 that coating insulin-loaded nanoparticles with chitosan could significantly improve the oral delivery of insulin. Furthermore, the rising investments in research and development, along with collaborative efforts in the field, are expected to provide additional opportunities for market growth, reinforcing the overall advancement of diabetes management solutions.

Restraints in the Diabetes Care Devices And Drugs Market

The growth of the global diabetes care devices and drugs market may be hindered by several factors, including limited reimbursement options, stringent regulations, and increasing obesity rates in certain regions. Additionally, the lack of awareness surrounding diabetes diagnosis and treatment, particularly in emerging markets, poses a significant challenge to market expansion. These obstacles can lead to reduced accessibility and adoption of diabetes care solutions, further impeding the development of the market. Addressing these issues will be essential to enhance growth prospects and improve the overall effectiveness of diabetes management strategies worldwide.

Market Trends of the Diabetes Care Devices And Drugs Market

The Diabetes Care Devices and Drugs market has experienced a notable positive trend, catalyzed by the COVID-19 pandemic, which heightened awareness and concern over diabetes management among patients. With diabetics facing elevated risks from the virus, the demand for advanced monitoring devices surged as individuals sought to manage their condition more effectively from home. This shift resulted in a significant increase in the adoption of home-based diabetes care solutions, driven by a desire to minimize hospital visits. As a result, the market has seen innovations in drug formulations and device technology aimed at improving blood glucose monitoring and overall diabetes management, indicating a sustained growth trajectory in response to evolving patient needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Diabetes Care Devices and Drugs Market Size by Type & CAGR (2025-2032)

• Market Overview
• BGM Devices
  • Self-Monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
  • Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receiver
• Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes and Needles
  • Jet Injectors

Global Diabetes Care Devices and Drugs Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Global Diabetes Care Devices and Drugs Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Homecare

Global Diabetes Care Devices and Drugs Market Size & CAGR (2025-2032)

• North America (Type, Distribution Channel, End-use)
  • US
  • Canada
• Europe (Type, Distribution Channel, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution Channel, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution Channel, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution Channel, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations